Page last updated: 2024-08-23

mefloquine and Ebola Hemorrhagic Fever

mefloquine has been researched along with Ebola Hemorrhagic Fever in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fisher, E; García-Sastre, A; He, S; Kouznetsova, J; Long, Y; Martínez-Romero, C; Motabar, O; Qiu, X; Sanderson, PE; Shinn, P; Sun, W; Tawa, G; Williamson, PR; Xu, M; Yang, S; Zheng, W	1

Other Studies

1 other study(ies) available for mefloquine and Ebola Hemorrhagic Fever

Article	Year
Synergistic drug combination effectively blocks Ebola virus infection. Antiviral research, 2017, Volume: 137 Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Clarithromycin; Drug Combinations; Drug Synergism; Ebolavirus; Hemorrhagic Fever, Ebola; High-Throughput Screening Assays; Humans; Mefloquine; Sphingomyelin Phosphodiesterase; Toremifene; Triazoles; Vero Cells; Virus Internalization	2017

Article

Year

Synergistic drug combination effectively blocks Ebola virus infection.

Antiviral research, 2017, Volume: 137

Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Clarithromycin; Drug Combinations; Drug Synergism; Ebolavirus; Hemorrhagic Fever, Ebola; High-Throughput Screening Assays; Humans; Mefloquine; Sphingomyelin Phosphodiesterase; Toremifene; Triazoles; Vero Cells; Virus Internalization

2017